Article Details

Biopharmaceutical firm taking next step in trials for intravitreal integrin antagonist

Retrieved on: 2021-08-17 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

Biopharmaceutical firm taking next step in trials for intravitreal integrin antagonist. View article details on hiswai:

Excerpt

According to the biopharmaceutical company, the multicenter, dose escalation study (NCT03666923) was designed to evaluate the safety and ...

Article found on: www.ophthalmologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up